Danielle deCampo, MD, PhD presented her retrospective study of genetic contributes to FIRES and RSE at the
Norse Family Conference, revealing a low genetic yield compared to the border landscape of epilepsy genetics. However … @IngoHelbig@ddecampo@JulieXXian
… database studies utilizing natural language processing have the potential to uncover novel genetic contributes for disorders that have historically been considered etiologically complex and challenged by small patient populations
Families who are interested in participating in an STXBP1 natural history study at a site near them can connect with the STXBP1 Foundation for site contact details
Where: CHOP team announcing a prospective, multi-site natural history study for STXBP1 in the United States
When: July 2023
@SarahRuggieroGC @JulieXXian@Prosser_Lab@IngoHelbig@curestxbp1
What do we need to consider when selecting an outcome measures for STXBP1? “Basically everything” — thank goodness we have expert PT and OTs! Much love for interdisciplinary teams @IngoHelbig@curestxbp1
What a privilege to have the team and opportunity to try and help my daughter and those like her live healthier, fuller lives. We will be a relentless force for good against #RareDisease.
@IngoHelbig@lab_davidson@ChildrensPhila@PennMedicine https://t.co/WkNHxn7XTc
Another highlight from #NORDsummit#RareDisease was reconnecting with Dr. Connie Lee from @AllianceToCure hearing her engaging talk regarding applying a ‘scalpel and not a hammer’ to mend relationships between patients, advocates, providers, and researchers in the name of DEI
Incredibly excited to represent the Helbig lab at the NORD #RareDisease 2022 summit, coffee and notebook are ready to go! Stay tuned for a poster on forming a concept disease model for #STXBP1 -related disorders @IngoHelbig@curestxbp1
Incredible and important work by Katie-Rose Sullivan to develop a Disease Concept Model for STXBP1-related disorders @curestxbp1 @SarahRuggieroGC @IngoHelbig @PennGenetics